Coagulation Factor IX (recombinant)

Coagulation Factor IX (recombinant)
Trade Name Benefix
Orphan Indication Hemophilia B
USA Market Approval USA
USA Designation Date 1994-10-03 00:00:00
Sponsor Genetics Institute, Inc.;87 Cambridge Park Drive;Cambridge, Massachusetts, 02140